Biosyntrx, Inc. Adds Three Scientific Advisory Board Members

By

COLORADO SPRINGS, Colo.— Biosyntrx, Inc., a nutritional biotechnology and healthy lifestyles education company in the ophthalmic sector, has added three new scientific advisory board members.

Lucy Young, MD, is associate professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. She is the director of the Lancaster Course in Ophthalmology and has been on its faculty since 1990.

Richard Davis, MD, is a physician, inventor and successful serial entrepreneur who has authored nearly 400 patents and trademarks worldwide, as well as sold four start-up companies to publicly traded companies. He is currently serving as the chairman, president and CEO of OgenX Therapeutics, a privately held mitochondrial medicines company focusing on solutions in Neurodegeneration, Oncology and Virology in humans and animals.

Vincent de Luise, MD, is assistant clinical professor of Ophthalmology at Yale University School of Medicine and Adjunct Clinical Assistant Professor of Ophthalmology at Weill Cornell Medical College. He serves on the editorial boards of the Cornea Journal and Eye World.